Former Biogen CEO Michel Vounatsos Joins Quris-AI Board
January 04, 2024 08:00 ET
|
Quris Technologies
Former Biogen CEO Michel Vounatsos Joins Quris-AI Board; Yossi Ben Amram Appointed President as BioAI Innovator Continues to Expand
Merck KGaA, Darmstadt, Germany and Quris-AI Expand Collaboration
September 28, 2023 08:00 ET
|
Quris Technologies
Merck KGaA and Quris-AI Expand Collaboration After a Successful Preclinical Study Assessed the Quris-AI BioAI Drug Safety Platform
独メルクとクリスAIが協働を拡大
September 28, 2023 08:00 ET
|
Quris Technologies
ボストンおよびイスラエル・テルアビブ発, Sept. 28, 2023 (GLOBE NEWSWIRE) -- 医薬品分野に革命をもたらしている人工知能 (AI) のイノベーターであるクリスAI (Quris-AI) は本日、大手サイエンス・テクノロジー会社の独メルク (Merck KGaA) (ドイツ・ダルムシュタット) との協働の拡大を発表した。...
Quris-AI Named to Fast Company’s Annual List of the World’s Most Innovative Companies for 2023
March 02, 2023 07:00 ET
|
Quris Technologies
BOSTON and TEL-AVIV, Israel, March 02, 2023 (GLOBE NEWSWIRE) -- Quris-AI, has been named to Fast Company’s prestigious annual list of the World’s Most Innovative Companies for 2023. This year’s...
Quris-AI and MBZUAI to launch world-class Bio-AI center in Abu-Dhabi
January 18, 2023 06:14 ET
|
Quris Technologies
ABU DHABI, United Arab Emirates, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Quris-AI and Mohamed bin Zayed University of Artificial Intelligence (MBZUAI) signed an agreement during Abu Dhabi Sustainability...
Quris Earns Additional Seed Investment Led by SoftBank Vision Fund 2
December 20, 2022 08:00 ET
|
Quris Technologies
BOSTON and TEL-AVIV, Israel, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Quris, an artificial intelligence (AI) innovator disrupting the pharmaceutical arena, today announced it has secured an additional $9...
Merck KGaA, Darmstadt, Germany, Enters into Option Agreement with Quris on its BioAI Platform for Clinical Safety Prediction
February 10, 2022 00:00 ET
|
Quris Technologies
BOSTON and TEL-AVIV, Israel, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Quris, an artificial intelligence (AI) innovator disrupting the pharmaceutical arena, today announced it has signed an agreement with...
Quris Closes $28 Million in Seed Funding From Top Institutional Investors
January 11, 2022 14:45 ET
|
Quris Technologies
BOSTON and TEL-AVIV, Israel, Jan. 11, 2022 (GLOBE NEWSWIRE) -- Quris, an artificial intelligence (AI) innovator disrupting the pharmaceutical arena, today announced the final close of $28 million in...
Quris Closes Critical Drug Development Gaps With New Clinical Prediction AI Platform
October 18, 2021 07:30 ET
|
Quris Technologies
BOSTON and TEL-AVIV, Israel, Oct. 18, 2021 (GLOBE NEWSWIRE) -- Quris, an artificial intelligence (AI) innovator disrupting the pharmaceutical arena, today launched the first clinical prediction AI...
Microtasking Market Research Report by Task Type, by Customer Type, by Task, by End-users, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
October 14, 2021 07:19 ET
|
ReportLinker
New York, Oct. 14, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Microtasking Market Research Report by Task Type, by Customer Type, by Task, by End-users, by Region...